- +POST AD
Actos: Uses, Dosage & Side Effects - DrugsActos (pioglitazone) is an oral diabetes medicine used to treat type 2 (non-insulin-dependent) diabetes. Includes Actos side effects, interactions and indications.
Pioglitazone - WikipediaPioglitazone (brand name Actos) is a prescription drug of the thiazolidinedione (TZD) class with hypoglycemic (antihyperglycemic, antidiabetic) action to treat diabetes.
Actos oral - WebMDFind patient medical information for Actos oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Actos – Type 2 Diabetes Drug, Uses & Side EffectsWhat is Actos? Actos is an oral Type 2 diabetes drug that comes in tablet form. It is not for use in treatment of Type 1 diabetes or diabetic ketoacidosis.
Actos (Pioglitazone Hydrochloride): Side Effects ...Learn about Actos (Pioglitazone Hydrochloride) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, and related medications.
Takeda Pharmaceuticals U.S.A., Inc.: Products Portfolio ...Brand Name Generic Name Prescribing Information; ACTOS: pioglitazone: Prescribing Information including boxed warning and medication guide: ACTOplus: met
Pioglitazone (By mouth) - National Library of Medicine ...Oct 01, 2016 · Pioglitazone (By mouth) pye-oh-GLI-ta-zone. Treats type 2 diabetes. Drug classes. Antidiabetic (About this - PubMed Health) Uses Uses of ... Actos. …
ACTOS® (pioglitazone hydrochloride) TabletsThiazolidinediones, including ACTOS, cause or exacerbate congestive heart failure in some patients (see WARNINGS). After initiation of ACTOS, and after dose increases ...
Actos Side Effects – Bladder Cancer, Heart Failure & MoreActos (pioglitazone) can cause serious side effects, including bladder cancer and heart failure. Patients who suffered may have legal options.
Actos - FDA prescribing information, side effects and usesActos official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.